Crossmark

Autogenic splenic implantation versus splenectomy in patients undergoing distal pancreatectomy for benign or low-grade malignant lesions of the distal pancreas: study protocol for a multicentre, open-label, randomized controlled trial (RESTORE)

Crossref DOI link: https://doi.org/10.1186/s13063-023-07714-1

Published Online: 2024-01-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hilal, Mohammed Abu

Kuemmerli, Christoph

Sijberden, Jasper P.

Moekotte, Alma

Zimmitti, Giuseppe

Alseidi, Adnan

Asbun, Horacio J.

Marudanayagam, Ravi

Bonds, Morgan

Kunzler, Filipe

Sutcliffe, Robert

Eren, Efrem

Primrose, John N.

Williams, Anthony P.
Funding

Funding for this research was provided by:

Liver and pancreatic cancer charity
License Information

Text and Data Mining valid from 2024-01-09

Version of Record valid from 2024-01-09
More Information

Article History

Received: 22 February 2023

Accepted: 7 October 2023

First Online: 9 January 2024

Declarations

:

: Ethical approval has been obtained from the South-Central Hampshire Research Ethics Committee (reference number 18/SC/0364). All patients give informed consent prior to any study-related intervention.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below